Adempas Tablets and Mesalamine Controlled-Release Capsules
Determining the interaction of Adempas Tablets and Mesalamine Controlled-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: riociguat
Brand name: Adempas
Synonyms: Riociguat
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adempas Tablets-Mesalamine Delayed Release Tablets
- Adempas Tablets-Mesalamine Long-Acting Capsules (Apriso)
- Adempas Tablets-Mesalamine Long-Acting Capsules (Delzicol)
- Adempas Tablets-Mesalamine Long-Acting Capsules (Pentasa)
- Adempas Tablets-Mesalamine rectal
- Adempas Tablets-Mesalamine Rectal Enema
- Mesalamine Controlled-Release Capsules-Adenocard
- Mesalamine Controlled-Release Capsules-Adenoscan
- Mesalamine Controlled-Release Capsules-Adenosine
- Mesalamine Controlled-Release Capsules-Adenosine Intravenous
- Mesalamine Controlled-Release Capsules-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Mesalamine Controlled-Release Capsules-Adenovirus Vaccine